OptimizeRx (OPRX) Operating Leases: 2019-2025
Historic Operating Leases for OptimizeRx (OPRX) over the last 7 years, with Q3 2025 value amounting to $507000.0.
- OptimizeRx's Operating Leases rose 1601.83% to $507000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $507000.0, marking a year-over-year increase of 1601.83%. This contributed to the annual value of $209000.0 for FY2024, which is 4366.58% down from last year.
- According to the latest figures from Q3 2025, OptimizeRx's Operating Leases is $507000.0, which was up 1601.83% from $548000.0 recorded in Q2 2025.
- In the past 5 years, OptimizeRx's Operating Leases registered a high of $548000.0 during Q2 2025, and its lowest value of $14019.0 during Q2 2023.
- Over the past 5 years, OptimizeRx's median Operating Leases value was $260614.0 (recorded in 2021), while the average stood at $277380.6.
- Its Operating Leases has fluctuated over the past 5 years, first plummeted by 9261.39% in 2023, then soared by 338812.33% in 2024.
- Over the past 5 years, OptimizeRx's Operating Leases (Quarter) stood at $236726.0 in 2021, then crashed by 38.95% to $144532.0 in 2022, then surged by 156.69% to $371000.0 in 2023, then crashed by 43.67% to $209000.0 in 2024, then skyrocketed by 142.58% to $507000.0 in 2025.
- Its Operating Leases stands at $507000.0 for Q3 2025, versus $548000.0 for Q2 2025 and $310000.0 for Q1 2025.